It is well known that in breast cancer Her2 was found to be a negative prognostic factor [30], but for GaC there still seems to be no consensus, despite the fact that the first studies demonstrated an association between positive Her2 status and poor prognosis. The gene discussed is ERBB2; the disease is breast carcinoma.